Specified Drug Use-Results Survey on "long-term use for Nouriast Tablet "
Not Applicable
- Conditions
- s diseaseParkinson'
- Registration Number
- JPRN-UMIN000030014
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
When the contract is not concluded When the number of contract cases has been reached If the administration start date is out of the contract period For already registered patients When more than 15 days have elapsed from the administration start date Patients used for diseases other than approved efficacy benefits
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety 1.Development of ADR/infectious diseases (type, indication rate, etc.) 2.Investigation of factors considered to affect safety 3.Status of serious adverse events Effectiveness 1.Effective rate 2.Examination of factors considered to affect the effectiveness
- Secondary Outcome Measures
Name Time Method